Impact of empagliflozin added on to basal insulin in type 2 diabetes inadequately controlled on basal insulin: a 78-week randomized, double-blind, placebo-controlled trial
Rosenstock, J., Jelaska, A., Zeller, C., Kim, G., Broedl, U. C., Woerle, H. J.Volume:
17
Language:
english
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.12503
Date:
October, 2015
File:
PDF, 1.19 MB
english, 2015